Cargando…
Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
Lithium has shown the capacity to: a) inhibit the replication of several types of viruses, some of which are similar to the SARS-CoV-2 virus, b) increase the immune response by reducing lymphopenia, and c) reduce inflammation by preventing or reducing the cytokine storm. In the present study, we hav...
Autores principales: | Spuch, Carlos, López-García, Marta, Rivera-Baltanás, Tania, Rodrígues-Amorím, Daniela, Olivares, José M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481472/ https://www.ncbi.nlm.nih.gov/pubmed/32973537 http://dx.doi.org/10.3389/fphar.2020.557629 |
Ejemplares similares
-
Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
por: Rudd, Christopher E.
Publicado: (2020) -
A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020) -
Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients
por: Spuch, Carlos, et al.
Publicado: (2022) -
Changes in Membrane Protein Clustering in Peripheral Lymphocytes in an Animal Model of Depression Parallel Those Observed in Naïve Depression Patients: Implications for the Development of Novel Biomarkers of Depression
por: Romay-Tallon, Raquel, et al.
Publicado: (2018) -
Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder
por: Caruncho, Hector J., et al.
Publicado: (2019)